Analysis of Community Behavioral Factors Influencing the Accuracy of Diarrhea Drug Use Using the Health Belief Model

Abstract

Diarrhea can be caused by infectious diseases that lead to relatively high morbidity and mortality rates. Diarrhea refers to a continuous flow of bowel movements that occurs suddenly and exceeds the normal limit, usually occurring more than 3 times in 24 hours and lasting less than 14 days. The Health Belief Model (HBM) can be used to identify factors that influence individual health behaviors. This study aimed to analyze the behavioral factors of the community towards the appropriate use of diarrhea drugs in the city of Biak Papua using the HBM. This was an observational study with a cross-sectional approach. There were 78 respondents and the data were analyzed using the Spearman rank test. According to the findings, each of the HBM components that were examined had a significant influence on the accuracy of drug use in diarrhea patients (p < 0.05). 15.2% of the respondents had a very precise accuracy, 46.2% had adequate accuracy, 24.4% had inaccurate accuracy, and 14.1% had very inaccurate accuracy. The correlation values of each perception were: perception of vulnerability = 0.549; perception of seriousness = 0.494; perception of obstacles = -0.371; perceived benefits = 0.226; and self-confidence = 0.513. It can be concluded that there is a relationship between behavior and accuracy in the use of diarrhea medicine in Biak City, Papua.


Keywords: diarrhea, accuracy, Health Belief Model (HBM)

References
[1] N. Utami and N. Luthfiana, “Faktor-Faktor yang Memengaruhi Kejadian Diare pada Anak.,” Majority. vol. 5, pp. 101–106, 2016.


[2] R.N. Atmadani, O. Nkoka, S.L. Yunita, and Y.-H. Chen, “Self-medication and knowledge among pregnant women attending primary healthcare services inMalang, Indonesia: a cross-sectional study.,” BMC Pregnancy and Childbirth. vol. 20, no. 1, pp. 1–11, 2020.


[3] S.L. Yunita, R.N. Atmadani, and M. Titani, “Faktor-faktor Yang Mempengaruhi Pengetahuan Dan Perilaku Penggunaan Antibiotika Pada Mahasiswa Farmasi Universitas Muhammadiyah Malang.,” Pharmaceutical Journal of Indonesia. vol. 6, no. 2, pp. 119–123, 2021.


[4] G. Prakasiwi, I.R. Hidayati, and S.L. Yunita, “ANALISIS PENGGUNAAN ASAM MEFENAMAT DARI PERESEPAN OBAT RAWAT JALAN DI PUSKESMAS SINGOSARI DENGAN METODE ATC / DDD ( Anatomical Therapeutic Chemical / Defined Daily Dose ) ANALYSIS OF MEFENAMIC ACID FROM PREPARATION OF MEDICINES AT THE SINGOSARI HEALTH CEN.,” vol. 16, no. 02, pp. 178–187, 2020.


[5] D.S. Putra, R.N. Atmadani, and I.R. Hidayati, “Relationship between knowledge level of hiv/aids patient with antiretroviral adherence in primary healthcare service in Malang City.,” Journal of HIV/AIDS & Social Services. pp. 1–18, 2021.


[6] N.F. Sari, I.R. Hidayati, and R.N. Atmadani, “Hubungan Pengetahuan tentan Penggunaan OAD pada Pasien Diabetes Mellitus Tipe 2 terhadap Kepatuhan Penggunaan Obat Antidiabetes Oral di Puskesmas Singosari Malang.,” Jurnal Kesehatan Islam: Islamic Health Journal. vol. 10, no. 2, pp. 65–71, 2021.


[7] L.H. Tias, L. Pristianty, and I.R. Hidayati, “Behavioral factor analysis of accuracy in using diarrhea medicines at Arjuno Health Center, Malang City with the Health Belief Model (HBM) approach.,” Farmasains: Jurnal Farmasi …. pp. 2–6, 2020.


[8] H.S. Brunnert and V.V. Hagelstrom, “Regency.,” Present Day Political Organization of China. vol. 6, no. 1, pp. 51–51, 2021.


[9] Y. Fitriani, L. Pristianty, and A. Hermansyah, “Pendekatan Health Belief Model (HBM) untuk Menganalisis Kepatuhan Pasien Diabetes Melitus Tipe 2 dalam Menggunakan Insulin.,” PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia). vol. 16, no. 2, p. 167, 2019.


[10] T. Nasiatin and I.N. Hadi, “Determinan Perilaku Hidup Bersih dan Sehat Pada Siswa Sekolah Dasar Negeri.,” Faletehan Health Journal. vol. 6, no. 3, pp. 118–124, 2019.


[11] I.R. Hidayati, D.A. Damayanti, and L. Pristianty, “Analysis of behavioral factors on medications in gout patients with health belief model theory.,” Journal of Global Pharma Technology. vol. 12, no. 8, pp. 79–84, 2020.